CHANGE IN BLOOD GELSOLIN CONCENTRATION IN RESPONSE TO PHYSICAL EXERCISE by Jan Górski et al.
Biology of Sport, Vol. 30 No3, 2013   169
Change in blood gelsolin concentration in response to physical exercise
Reprint request to:
Robert Bucki
University of Pennsylvania
Institute for Medicine and Engineering
1010 Vagelos Research Laboratories
3340 Smith Walk
Philadelphia, PA, 19104 USA
Phone: 00-1-215 573 9787,  
Fax: 00-1-215 573 6815
e-mail: buckirob@mail.med.upenn.edu
 Accepted 
for publication   
15.06.2013
INTRODUCTION
Plasma gelsolin (pGSN) represents one of the three currently described 
isoforms of gelsolin [26,28]. This PIP2- and calcium-regulated pro-
tein circulates in blood plasma at a concentration of ~250 µg · ml
-1 
and is primarily involved in the rapid severing and removal of actin 
filaments released into the bloodstream from dead and injured 
cells [17]. This function prevents several toxic effects of circulating 
F-actin, which activates platelets, slows down fibrinolysis by binding 
to plasmin [3,17], increases blood viscosity [11], and compromises 
the viability of endothelial cells [9]. Additionally, direct interaction 
of gelsolin with bioactive lipids such as lipopolysaccharide [1], lipo-
teichoic acid [2, 4], lysophosphatidic acid [19], platelet-activating 
factor [23] and sphingosine 1-phosphate [6] reduces the ability of 
these molecules to induce cell activation and gelsolin’s ability to 
sever F-actin. All gelsolin isoforms are encoded by a single gene 
located on chromosome 9 in humans [15]. Skeletal, cardiac, and 
smooth muscles have large amounts of pGSN mRNA, account for   
a large fraction of body mass and total protein synthesis, and they 
are the major source of plasma gelsolin [15]. So far, the factors that 
regulate pGSN expression in muscles and pGSN concentration in 
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blood are not defined [5,18]. The observed decrease of blood   
gelsolin concentration in patients with a variety of conditions, includ-
ing acute respiratory distress syndrome (ARDS) [21], acute liver 
injury [12], sepsis [16], malaria [25], subarachnoid hemorrhage [7], 
traumatic brain injury [27] and neuroinfection [13], lacks clear patho-
physiological mechanisms. In this study we aim to evaluate chang-
es in pGSN concentration in male volunteers occurring during   
30–60 minutes of a workload corresponding to 70% of  
· VO2max. 
MATERIALS AND METHODS 
Recruitment of subjects. Healthy males (n=20) were recruited from 
students of the Faculty of Physical Education and Sport at the Józef 
Piłsudski University of Physical Education. They were assigned to 
either the untrained (UT, n = 10) or endurance trained (ET, n = 10) 
group. Requirements in study participation included lack of smoking, 
chronic disease and current medication use. Students who did not 
participate in any physical activity except for compulsory classes at 
the university (approx. 4 h per week of low intensity exercise) were 
included in the UT group. Athletes in the ET group were long distance 
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runners (average experience of 1.7–4.3 years, between 7 and 10 h 
per week). For each participant body composition was determined 
after overnight fasting using an Akern BIA-101 analyzer (Florence, 
Italy). The study was approved by the Ethical Committee for Human 
Studies of the Józef Piłsudski University of Physical Education.   
All subjects gave their informed consent prior to their inclusion in 
the study.
Exercise protocol
The study was conducted on two separate days over a 1-week pe-
riod. In the first step (day one), peak oxygen uptake ( 
· VO2max) was 
determined using a graded exercise test on a cycloergometer (Ergo-
medic 839E, Monark Exercise AB, Vansbro, Sweden) starting at   
1 W · kg
–1 of body weight for 3 min followed by increments of 
0.75 W · kg
–1 every 3 min until exhaustion. Oxygen consumption was 
monitored using an online system (Start 2000, MES, Cracow, Poland). 
In the second step (six or seven days later), the subjects performed 
either 30 (UT group) or 60 (ET group) minutes of exercise on   
the same cycloergometer at a workload estimated to elicit a load of 
70% of  
· VO2max. The period of exercise was chosen considering the 
differences in tolerance to exercise between the UT and ET groups 
(in a pilot study we observed that only 10% of UT subjects can 
complete the same 60 min of exercise to which the ET group was 
subjected in our experimental setting). Subjects were instructed to 
abstain from alcohol use during the 2 days preceding each visit to 
the laboratory. Both exercise bouts were performed in the morning, 
1 h after a light carbohydrate-rich breakfast.
Blood collection 
Blood samples were drawn through a catheter inserted into an an-
tecubital vein into 4.3 ml plastic tubes containing 0.43 ml of 0.106 M 
sodium citrate solution as an anticoagulant (Sarstedt, Nümbrecht, 
Germany). Samples were taken just before exercise, after 30 and   
60 (ET group only) minutes of pedaling, and after a 30-min rest.   
The catheter was kept patent by flushing it regularly with isotonic 
NaCl solution. Immediately after sampling, blood was centrifuged at 
300 g for 10 min at room temperature and plasma was transferred 
to a fresh plastic tube. Supernatant was then transferred to a fresh 
plastic tube and re-centrifuged at 5000 g for 10 min to obtain 
platelet-free plasma. All samples were stored at -80°C until analysis. 
Plasma protein concentration was measured using the BCA protein 
assay kit (Sigma). Bovine serum albumin (fatty acid free, Sigma) was 
used as a standard. Three volunteers from the ET group were unable 
to complete the exercise protocol. 
Quantitative immunoblotting
Plasma samples were boiled in the presence of sample buffer for 10 
min and subjected to electrophoresis on 10% sodium dodecyl sulfate 
(SDS)-polyacrylamide. Samples loaded in each gel were accompanied 
by recombinant human plasma gelsolin standard (loaded in a con-
centration range comparable to the gelsolin concentration in   
the samples). After electrophoresis, proteins were transferred to PVDF 
membranes (Amersham Biosciences, Little Chalfont, UK). The mem-
brane was then blocked by incubation in 5% (w/v) non-fat dry milk 
dissolved in TBS-T (150 mM NaCl, 50 mM TRIS, 0.05% Tween 20, 
pH = 7.4). Transferred proteins were probed with a monoclonal 
anti-human gelsolin antibody (Sigma, St. Louis, MO, USA) used at 
a 1:10000 dilution in TBS-T. After incubation with HRP-conjugated 
secondary antibodies (1:20000 dilution), immunoblots were devel-
oped with the Fuji Film LAS-300 system using an ECL Plus HRP-
targeted chemiluminescent substrate (Amersham Biosciences, Little 
Chalfont, UK). Western blots were quantified by densitometric anal-
ysis (Image Gauge - version 4.22 software; Fuji Photo Film Co, USA). 
The standard curve for determination of gelsolin concentration was 
prepared by loading 5, 10, 15, and 30 ng gelsolin in separate lanes 
of the gel. The intensity of each band on the Western blot minus   
the background signal was plotted versus the known amount of 
gelsolin and fitted to a straight line (R
2 ≥ 0.9); the graph was used 
as a standard curve to determine unknown gelsolin levels in simul-
taneously assayed samples from UT and ET subjects [21].
Statistical analysis
Data are reported as mean ± SD. Data analysis was performed using 
two-way analysis of variance (ANOVA) with appropriate post hoc test.
RESULTS 
The average age of subjects (all male) included in the study for   
UT (n=10) and ET (n=10) groups was 20.4±0.7 and 21.1±0.9 
years, and lean body mass was 64.6±7.6 and 58.4±2.9 kg respec-
tively. Body mass index (kg · m
-2) and % of body fat for the UT and 
ET groups were 22.6±2.3 versus 21±1.3 and 11.6±3.2 versus 
10.6±1.4. There was a statistically significant difference (p<0.05) 
between  
· VO2 max (ml · kg
 -1 · min
 -1) in the UT and ET groups (47.3±3 
versus 57.3±6.5). Total protein analysis in plasma samples did not 
differ between UT and ET groups. As indicated by data shown in 
figure 1, Western blot analysis of gelsolin concentration in 8 of 10 
subjects included in the UT group reveals a decrease after 30 minutes 
of exercise. At the same time point in 6 of 10 subjects included in 
the ET group, blood gelsolin concentration increased by more than 
10% of the initial concentration (time 0’). On average, blood gelso-
lin concentration in the UT group for time 0’, 30’ - EX, and 30’ post 
EX was 238.7±66.5, 167.6±58.7 and 188±88.2 respectively. 
The difference between gelsolin concentration at time 0’ and 30’ - EX 
in the UT group reached statistical significance (p<0.05). In the ET 
group, average blood gelsolin concentration at time 0’, 30’ - EX, 60’ 
- EX and 30’ post EX was 244.2±53.6, 271.5±74.6, 213.9±49.6 
and 213.8±68.4 respectively. 
DISCUSSION 
Exercise training elicits a number of adaptive changes in skeletal 
muscle that result in improved metabolic efficiency. Up to now   
the molecular mechanisms mediating the cellular adaptations to ex-  
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ercise training in human skeletal muscle have not been fully defined 
and several mediators, such as catecholamines, adrenocorticotrophic 
hormone, growth hormone, and proteins associated with skeletal 
muscle adaptation to the stress of contractile activity such as heat 
shock proteins (HSPs), have been proposed to govern this pro-
cess [20,24]. Since muscle tissue devotes ~3% of its metabolic 
power to synthesis of extracellular gelsolin [14] it is plausible that 
increasing gelsolin production occurs in response to exercise. We 
found that training prevents a decrease of blood gelsolin associated 
with intense exercise, indicating that an increase of pGSN expression 
might occur as part of adaptive changes to exercise in skeletal mus-
cle. However, a recent study in which alterations in protein abundance 
in skeletal muscle after one bout of exhaustive exercise using proteomic 
analysis was performed did not show any alteration in gelsolin expres-
sion [10]. Such an increase might not be easy to capture based on 
evaluation of blood gelsolin concentration if the increasing production 
is masked due to increasing demand by the extracellular actin buffer-
ing system. In a recent study, a decreased concentration of vitamin 
D binding protein which also contributes to the blood actin buffering 
system was observed after a one-hour exercise bout to exhaustion in 
obese subject [22]. However, no changes in blood gelsolin concentra-
tion were observed in those subjects. An observed decrease of blood 
FIG. 1. GELSOLIN CONCENTRATION IN PLASMA SAMPLES COLLECTED FROM UNTRAINED (PANELS A AND C) AND ENDURANCE TRAINED (PANELS 
B AND D) VOLUNTEERS. FROM ALL STUDY PARTICIPANTS, BLOOD SAMPLES WERE TAKEN BEFORE EXERCISE (TIME 0’), AT 30 MINUTES OF 
EXERCISE (30’ - EX) AND 30 MINUTES AFTER COMPLETION OF EXERCISE (30’ POST EX). ADDITIONALLY, IN THE ET GROUP BLOOD WAS ALSO 
COLLECTED AT 60 MINUTES OF EXERCISE (60’ - EX). PANEL A AND B SHOW CHANGES OF BLOOD GSN CONCENTRATION IN INDIVIDUAL SUBJECTS 
BETWEEN TIME 0’ AND 30 MINUTES OF EXERCISE IN UT AND ET GROUPS RESPECTIVELY. BOX PLOTS ON PANELS C AND D DISPLAY DIFFERENCES 
IN BLOOD GELSOLIN CONCENTRATION AT INDICATED TIME POINTS IN UT AND ET GROUPS RESPECTIVELY. THE HORIZONTAL LINE IN THE BOX 
INDICATES THE MEDIAN. PANEL E SHOWS A REPRESENTATIVE IMAGE OF WESTERN BLOT ANALYSIS OF 4 PLASMA SAMPLES TAKEN FROM   
1 SUBJECT OF THE ET GROUP . 
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gelsolin concentration in untrained subjects indicates that endurance 
training might increase the ability of muscle tissue to express plasma 
gelsolin, which might potentially compensate increasing demand for 
gelsolin by the extracellular actin buffering system. Administration of 
recombinant human plasma gelsolin was proposed as a treatment for 
different conditions in which hypogelsolinemia was observed [8].   
A better understanding of factors that regulate gelsolin production 
might provide an alternative therapy in which stimulation of endog-
enous plasma gelsolin by muscle tissue might be used to maintain   
a healthy gelsolin concentration. A study of blood gelsolin changes 
during exercise correlated with hormonal and metabolic screening 
might provide a better strategy to recognize these factors.
CONCLUSIONS 
It is concluded that training prevents a decrease of blood gelsolin 
associated with intense exercise. This may indicate that an increase 
of pGSN expression might occur as part of adaptive changes to ex-
ercise in skeletal muscle.
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